World-Class Academic Medical Center Acquires Synaptive's Next Generation Robotic System for Minimally Invasive Neurosurgery
Friday, July 20, 2018
Synaptive Medical Inc., a Toronto-based Medtech, today announced that Duke University Medical Center has acquired its connected neurosurgery system. Modus V ™, the company's flagship robotic and automated imaging technology, sets the benchmark for visual precision in advanced minimally invasive surgical procedures and skull and back procedures.
"The Duke Center is a historic leader in the medical field, including minimally invasive cranial surgery," said Peter Wehrly, CEO of Synaptive. "He has a long history in neurosurgical innovation and thought leadership. We are proud to make our devices and software available to their teams to enable them to provide the best possible care for their patients. "
Modus V is an automated robotic arm equipped with a high power digital microscope that provides an unprecedented picture of patient anatomy. With the most powerful optical solutions on the market and a robotic technology originally developed for the International Space Station, Modus V enables surgeons to perform less invasive procedures with greater precision. In some cranial procedures, it could allow interventions that were previously considered unrealizable.
The Duke Center also purchased the Synaptive BrightMatter ™ Integrated Surgical Platform. BrightMatter's planning automates the production of cerebral tract tract imaging, which maps the white matter's sensitive pathways that control vision, mobility, and other bodily functions. This feature provides surgeons with dynamic 3D visualization of the brain that can enable less invasive procedures and potentially safer surgical pathways. For patients, these less invasive procedures can decrease complications and speed up recovery times.
"Among other things, the future of neurosurgery involves studying the effective use of technology to automate today's manual processes and by analyzing the benefits of adopting robotic solutions that have the potential to make these procedures less traumatic for patients, and are more accurate, "said Dr. Patrick Codd, neurosurgeon at the Duke Cancer Center and head of the minimally invasive neurosurgery program.
"The combination of our technology with the Duke Center's intraoperative MRI creates very promising opportunities to discover how its integration could lead to improved surgical outcomes in patients," said Cameron Piron, co-founder and president of Synaptive. "The Duke Center's expertise in glioma surgery, immunology and immunotherapy also makes it an ideal partner, and we look forward to working with their neurosurgical team to deepen our knowledge and stimulate our development."
The Preston Robert Tisch Brain Tumor Center at the Duke Center is known worldwide for its surgical advances in care and research, and treats approximately 700 patients a year.
About Synaptive Medical
Synaptive Medical Inc., a Toronto-based medical device and device company, works with leading clinicians and healthcare systems to revolutionize products and services across traditional barriers to enable continuous improvement provision of health care, inside and outside the operating theater. Its integrated BrightMatter ™ solutions - including surgical planning, guidance and visualization, and an informatics platform - are designed to provide clinicians with the right information they need to ensure the best possible outcomes for patients.
The text of the communiqué resulting from a translation must in no way be considered official. The only version of the release that is authentic is that of the release in its original language. The translation will always have to be confronted with the source text, which will make jurisprudence.
contacts
Media:
Synaptive Medical, Inc.
Elizabeth Monier-Williams, 647-925-3435 ext. 169
Director of Marketing Communications
elizabeth.monierwilliams@synaptivemedical.com